VTE Protocol Development Group: C Kirke (Clinical Lead, Medication Safety Programme, National Quality Improvement Team), F Ni Ainle (Consultant Haematologist, Rotunda and Mater Hospitals), D O’Keeffe (Consultant Haematologist, University Hospital Limerick), C Bergin (Clinical Lead, Infectious Diseases, HSE and Consultant in Infectious Diseases, St James’s Hospital), N O’Connell (Consultant Haematologist, St James’s Hospital), M Watts (Consultant Physician, University Hospital Limerick), V Hamilton (National Clinical Advisory and Group Lead, HSE Acute Operations and Consultant Anaesthetist, University Hospital Waterford), M Pate (Specialist Pharmacist, Medication Safety Programme, HSE National QI Team), A Cronin (Administrator, Medication Safety Programme, HSE National QI Team).
VTE Patient Information Development Group: AM O’Neill (CEO, Thrombosis Ireland), C Kirke (as above), M Pate (as above), A Cronin (as above), F Ni Ainle (as above).
Purpose: This guidance is to clarify current recommendations for prevention of VTE and patient information for hospitalised adult medical or COVID-19 patients.
Target Audience: All healthcare professionals in acute hospitals (protocol and patient information). All patients in acute hospitals (patient information).
Assess all patients as soon as possible (within 14 hours) after the decision to admit. Reassess at consultant review and if clinical condition changes
People at higher risk of blood clots include:
The people in the groups above need information about:
Blood clot alert cards, posters and pull up banners are available on www.safermeds.ie and www.thrombosisireland.ie The HSE has distributed alert cards to all acute hospitals in February 2020. For queries about alert cards or more information, contact firstname.lastname@example.org
CD19-120_Appendix Thrombosis Ireland Alert Card. (Download PDF)
National Health Library & Knowledge Service. Health Service Executive. Dr. Steevens' Hospital, Dublin 8. Tel: 01-6352555/8. Email: email@example.com